Frazier Life Sciences Raises $1.3bn To Fund Start-Ups Through Value-Creating Data

Fund XII Eclipses Prior $987m VC Fund In 2022

Frazier Life Sciences will put 40%-50% of Fund XII into company creation and 30% into series A rounds (Shutterstock)

More from Financing

More from Business